EKF Diagnostics (LON:EKF) Sets New 1-Year High - Time to Buy?

Key Points

• EKF Diagnostics shares hit a new 52-week high of GBX 31.90 ($0.43) during trading on Wednesday, with a trading volume of 125,938 shares.
• The company has a market capitalization of £143.26 million and a notably high P/E ratio of 2,311.59, indicating potential valuation concerns.
• EKF specializes in diagnostic solutions and operates five manufacturing sites across the US and Germany, providing products to over 120 countries.

EKF Diagnostics Holdings plc (LON:EKF - ) shares reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 31.90 ($0.43) and last traded at GBX 31.90 ($0.43), with a volume of 125938 shares changing hands. The stock had previously closed at GBX 31 ($0.42).

EKF Diagnostics Price Performance

The firm's fifty day simple moving average is GBX 27.78 and its 200 day simple moving average is GBX 24.54. The firm has a market cap of £143.26 million, a P/E ratio of 2,311.59 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.